T lymphocyte autoreactivity in inflammatory mechanisms regulating atherosclerosis

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Profumo, Elisabetta ^a   Buttari, Brigitta ^a   Saso, Luciano ^b   Capoano, Raffaele ^b   Salvati, Bruno ^b   Riganò, Rachele ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; AUTOANTIGEN; BETA2 GLYCOPROTEIN 1; COLLAGEN; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNITY; B LYMPHOCYTE; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHLAMYDOPHILA PNEUMONIAE; COLLAGEN SYNTHESIS; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HELPER CELL; IMMUNOREACTIVITY; MACROPHAGE; MONOCYTE; OXIDATIVE STRESS; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ATHEROSCLEROSIS; AUTOANTIGENS; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS;

EID: 84872140196     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/157534     Document Type: Review

References (111)

1. Bartoloni E., Shoenfeld Y., Gerli R., Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care and Research 2011 63 2 178 183 2-s2.0-79551566012 10.1002/acr.20322
2. Libby P., Okamoto Y., Rocha V. Z., Folco E., Inflammation in atherosclerosis: transition from theory to practice. Circulation Journal 2010 74 2 213 220 2-s2.0-75749148425 10.1253/circj.CJ-09-0706
3. van Leuven S. I., Franssen R., Kastelein J. J., Levi M., Stroes E. S. G., Tak P. P., Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008 47 1 3 7 2-s2.0-37349089153 10.1093/rheumatology/kem202 (Pubitemid 350286254)
4. Girn H. R. S., Orsi N. M., Homer-Vanniasinkam S., An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease. Vascular Medicine 2007 12 4 299 309 2-s2.0-38449101883 10.1177/1358863X07083387
5. Nilsson J., Wigren M., Shah P. K., Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis. Trends in Cardiovascular Medicine 2009 19 8 272 276 2-s2.0-77952527041 10.1016/j.tcm.2010.02.010
6. Liehn E. A., Zernecke A., Postea O., Weber C., Chemokines: inflammatory mediators of atherosclerosis. Archives of Physiology and Biochemistry 2006 112 4-5 229 238 2-s2.0-33845900465 10.1080/13813450601093583 (Pubitemid 46018364)
7. Hansson G. K., Libby P., The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology 2006 6 7 508 519 2-s2.0-33745571976 10.1038/nri1882 (Pubitemid 43980523)
8. Bernhagen J., Krohn R., Lue H., Gregory J. L., Zernecke A., Koenen R. R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S. R., Bucala R., Hickey M. J., Weber C., MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Medicine 2007 13 5 587 596 2-s2.0-34249066942 10.1038/nm1567 (Pubitemid 46828480)
9. Kleemann R., Zadelaar S., Kooistra T., Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovascular Research 2008 79 3 360 376 2-s2.0-48749110858 10.1093/cvr/cvn120
10. De Villiers W. J. S., Smith J. D., Miyata M., Dansky H. M., Darley E., Gordon S., Macrophage phenotype in mice deficient in both macrophage-colony- stimulating factor (Op) and apolipoprotein E. Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 4 631 640 2-s2.0-0031977846 (Pubitemid 28177905)
11. Rajavashisth T., Qiao J. H., Tripathi S., Tripathi J., Mishra N., Hua M., Wang X. P., Loussararian A., Clinton S., Libby P., Lusis A., Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. Journal of Clinical Investigation 1998 101 12 2702 2710 2-s2.0-0032525907 (Pubitemid 28294579)
12. Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., Di Pucchio T., Connolly J., Fay J. W., Pascual V., Palucka A. K., Banchereau J., Dendritic cell subsets in health and disease. Immunological Reviews 2007 219 1 118 142 2-s2.0-34548544885 10.1111/j.1600-065X.2007.00551.x (Pubitemid 47393528)
13. Mallat Z., Ait-Oufella H., Tedgui A., Regulatory T-cell immunity in atherosclerosis. Trends in Cardiovascular Medicine 2007 17 4 113 118 2-s2.0-34247559732 10.1016/j.tcm.2007.03.001 (Pubitemid 46670020)
14. Østerud B., Bjørklid E., Role of monocytes in atherogenesis. Physiological Reviews 2003 83 4 1069 1112 2-s2.0-0141639811 (Pubitemid 37222268)
15. Yilmaz A., Lochno M., Traeg F., Cicha I., Reiss C., Stumpf C., Raaz D., Anger T., Amann K., Probst T., Ludwig J., Daniel W. G., Garlichs C. D., Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004 176 1 101 110 2-s2.0-4043114983 10.1016/j.atherosclerosis.2004.04.027 (Pubitemid 39078651)
16. Ranjit S., Dazhu L., Potential role of dendritic cells for progression of atherosclerotic lesions. Postgraduate Medical Journal 2006 82 971 573 575 2-s2.0-33749177382 10.1136/pgmj.2005.036970 (Pubitemid 44476212)
17. Hansson G. K., Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 2005 352 16 1685 1626 2-s2.0-17644412023 10.1056/NEJMra043430 (Pubitemid 40530235)
18. Szodoray P., Timar O., Veres K., Der H., Szomjak E., Lakos G., Aleksza M., Nakken B., Szegedi G., Soltesz P., Th1/Th2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines-immunological alterations in acute coronary syndrome and stable coronary artery disease. Scandinavian Journal of Immunology 2006 64 3 336 344 2-s2.0-33747062417 10.1111/j.1365-3083.2006.01816.x (Pubitemid 44215124)
19. Tuomisto K., Jousilahti P., Sundvall J., Pajunen P., Salomaa V., C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality: a population-based, prospective study. Thrombosis and Haemostasis 2006 95 3 511 518 2-s2.0-33645538914 10.1160/TH05-08-0571
20. Heeschen C., Dimmeler S., Hamm C. W., Fichtlscherer S., Boersma E., Simoons M. L., Zeiher A. M., Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003 107 16 2109 2114 2-s2.0-0038078373 10.1161/01.CIR.0000065232.57371.25 (Pubitemid 36532192)
21. Yamagami H., Kitagawa K., Hoshi T., Furukado S., Hougaku H., Nagai Y., Hori M., Associations of serum IL-18 levels with carotid intima-media thickness. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 7 1458 1462 2-s2.0-21544437417 10.1161/01.ATV.0000168417.52486.56 (Pubitemid 40923368)
22. Elkind M. S. V., Rundek T., Sciacca R. R., Ramas R., Chen H. J., Boden-Albala B., Rabbani L., Sacco R. L., Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis 2005 180 1 181 187 2-s2.0-17044366542 10.1016/j.atherosclerosis.2004.11.015
23. De Lemos J. A., Morrow D. A., Sabatine M. S., Murphy S. A., Gibson C. M., Antman E. M., McCabe C. H., Cannon C. P., Braunwald E., Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003 107 5 690 695 2-s2.0-0037432168 10.1161/01.CIR.0000049742.68848.99 (Pubitemid 36222595)
24. Profumo E., Esposito C., Buttari B., Tosti M. E., Ortona E., Margutti P., Siracusano A., Sposato A., Costanzo A., Capoano R., Salvati B., Riganò R., Intracellular expression of cytokines in peripheral blood from patients with atherosclerosis before and after carotid endarterectomy. Atherosclerosis 2007 191 2 340 347 2-s2.0-33947156314 10.1016/j.atherosclerosis.2006.03.030 (Pubitemid 46400694)
25. Profumo E., Buttari B., Tosti M. E., Siracusano A., Ortona E., Margutti P., Capoano R., Salvati B., Riganò R., Association of intracellular pro- and anti-inflammatory cytokines in peripheral blood with the clinical or ultrasound indications for carotid endarterectomy in patients with carotid atherosclerosis. Clinical and Experimental Immunology 2008 152 1 120 126 2-s2.0-40449103756 10.1111/j.1365-2249.2008.03604.x (Pubitemid 351347556)
26. Dansky H. M., Charlton S. A., Harper M. M., Smith J. D., T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4642 4646 2-s2.0-0031001972 10.1073/pnas.94.9.4642 (Pubitemid 27194296)
27. Daugherty A., Puré E., Delfel-Butteiger D., Chen S., Leferovich J., Roselaar S. E., Rader D. J., The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. Journal of Clinical Investigation 1997 100 6 1575 1580 2-s2.0-0030771822 (Pubitemid 27425785)
28. Reardon C. A., Blachowicz L., White T., Cabana V., Wang Y., Lukens J., Bluestone J., Getz G. S., Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 6 1011 1016 2-s2.0-0035714952 (Pubitemid 34168661)
29. Song L., Leung C., Schindler C., Lymphocytes are important in early atherosclerosis. Journal of Clinical Investigation 2001 108 2 251 259 2-s2.0-0034952970 10.1172/JCI200111380 (Pubitemid 32656249)
30. + T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000 102 24 2919 2922 2-s2.0-0034642328
31. Tedgui A., Mallat Z., Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiological Reviews 2006 86 2 515 581 2-s2.0-33645891172 10.1152/physrev.00024.2005
32. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A., Recent advances on the role of cytokines in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 5 969 979 2-s2.0-79955632739 10.1161/ATVBAHA.110.207415
33. George J., Schwartzenberg S., Medvedovsky D., Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. Atherosclerosis 2012 222 2 519 523
34. Gupta S., Pablo A. M., Jiang X. C., Wang N., Tall A. R., Schindler C., IFN- γ potentiates atherosclerosis in ApoE knock-out mice. Journal of Clinical Investigation 1997 99 11 2752 2761 2-s2.0-0030974188 (Pubitemid 27259823)
35. Whitman S. C., Ravisankar P., Elam H., Daugherty A., Exogenous interferon- γ enhances atherosclerosis in apolipoprotein E-/- mice. American Journal of Pathology 2000 157 6 1819 1824 2-s2.0-0033635218
36. Koga M., Kai H., Yasukawa H., Yamamoto T., Kawai Y., Kato S., Kusaba K., Kai M., Egashira K., Kataoka Y., Imaizumi T., Inhibition of progression and stabilization of plaques by postnatal interferon- γ function blocking in ApoE-knockout mice. Circulation Research 2007 101 4 348 356 2-s2.0-34547951705 10.1161/CIRCRESAHA.106.147256 (Pubitemid 47267703)
37. Profumo E., Buttari B., Tosti M. E., Alessandri C., Valesini G., Marcuccio L., Tesori C., Capoano R., Salvati B., Riganò R., Identification of IP-10 and IL-5 as proteins differentially expressed in human complicated and uncomplicated carotid atherosclerotic plaques. International Journal of Immunopathology and Pharmacology 2010 23 3 775 782 2-s2.0-78149268176
38. Lam K. P., Chu Y. T., Kuo C. H., Wang W. L., Tok T. S., Chin Y. Y., Chen S. C. C., Hung C. H., Suppressive effects of procaterol on expression of IP-10/CXCL 10 and RANTES/CCL 5 by bronchial epithelial cells. Inflammation 2011 34 4 238 246 2-s2.0-79961172902 10.1007/s10753-010-9229-9
39. Takatsu K., Kouro T., Nagai Y., Interleukin 5 in the link between the innate and acquired immune response. Advances in Immunology 2009 101 C 191 236 2-s2.0-60449105149 10.1016/S0065-2776(08)01006-7
40. Davenport P., Tipping P. G., The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. American Journal of Pathology 2003 163 3 1117 1125 2-s2.0-0042926424 (Pubitemid 37040147)
41. Huber S. A., Sakkinen P., David C., Newell M. K., Tracy R. P., T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 2001 103 21 2610 2616 2-s2.0-0035967480 (Pubitemid 32521973)
42. King V. L., Szilvassy S. J., Daugherty A., Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 3 456 461 2-s2.0-0036124714 10.1161/hq0302.104905 (Pubitemid 34218754)
43. Miossec P., IL-17 and Th17 cells in human inflammatory diseases. Microbes and Infection 2009 11 5 625 630 2-s2.0-67349234068 10.1016/j.micinf.2009.04.003
44. O'Connor W. Jr., Kamanaka M., Booth C. J., Town T., Nakae S., Iwakura Y., Kolls J. K., Flavell R. A., A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nature Immunology 2009 10 6 603 609 2-s2.0-65749091607 10.1038/ni.1736
45. Zhou W., Dowell D. R., Huckabee M. M., Prostaglandin I2 signaling drives Th17 differentiation and exacerbates experimental autoimmune encephalomyelitis. PLoS One 2012 7 5, article e33518
46. Taleb S., Tedgui A., Mallat Z., Interleukin-17: friend or foe in atherosclerosis? Current Opinion in Lipidology 2010 21 5 404 408 2-s2.0-77957576742 10.1097/MOL.0b013e32833dc7f9
47. van Es T., van Puijvelde G. H. M., Ramos O. H., Segers F. M. E., Joosten L. A., van den Berg W. B., Michon I. M., de Vos P., van Berkel T. J. C., Kuiper J., Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochemical and Biophysical Research Communications 2009 388 2 261 265 2-s2.0-69249213893 10.1016/j.bbrc.2009.07.152
48. Erbel C., Chen L., Bea F., Wangler S., Celik S., Lasitschka F., Wang Y., Böckler D., Katus H. A., Dengler T. J., Inhibition of IL-17A attenuates atherosclerotic lesion development in ApoE-deficient mice. Journal of Immunology 2009 183 12 8167 8175 2-s2.0-76249103398 10.4049/jimmunol.0901126
49. Smith E., Prasad K. M. R., Butcher M., Dobrian A., Kolls J. K., Ley K., Galkina E., Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010 121 15 1746 1755 2-s2.0-77951485998 10.1161/CIRCULATIONAHA.109.924886
50. Gao Q., Jiang Y., Ma T., Zhu F., Gao F., Zhang P., Guo C., Wang Q., Wang X., Ma C., Zhang Y., Chen W., Zhang L., A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. Journal of Immunology 2010 185 10 5820 5827 2-s2.0-78650637747 10.4049/jimmunol.1000116
51. Chen S., Shimada K., Zhang W., Huang G., Crother T. R., Arditi M., IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. Journal of Immunology 2010 185 9 5619 5627 2-s2.0-78149490050 10.4049/jimmunol.1001879
52. Eid R. E., Rao D. A., Zhou J., Lo S. F. L., Ranjbaran H., Gallo A., Sokol S. I., Pfau S., Pober J. S., Tellides G., Interleukin-17 and interferon- γ Are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009 119 10 1424 1432 2-s2.0-64549126102 10.1161/CIRCULATIONAHA.108.827618
53. Liu Z., Lu F., Pan H., Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication. Atherosclerosis 2012 221 1 232 241
54. Taleb S., Romain M., Ramkhelawon B., Uyttenhove C., Pasterkamp G., Herbin O., Esposito B., Perez N., Yasukawa H., Van Snick J., Yoshimura A., Tedgui A., Mallat Z., Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. Journal of Experimental Medicine 2009 206 10 2067 2077 2-s2.0-70350433833 10.1084/jem.20090545
55. Liuzzo G., Goronzy J. J., Yang H., Kopecky S. L., Holmes D. R., Frye R. L., Weyand C. M., Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000 101 25 2883 2888 2-s2.0-0034720851 (Pubitemid 30415876)
56. Nakajima T., Schulte S., Warrington K. J., Kopecky S. L., Frye R. L., Goronzy J. J., Weyand C. M., T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002 105 5 570 575 2-s2.0-0037022209 10.1161/hc0502.103348 (Pubitemid 34123430)
57. Warrington K. J., Kent P. D., Frye R. L., Lymp J. F., Kopecky S. L., Goronzy J. J., Weyand C. M., Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Research & Therapy 2005 7 5 R984 R991 2-s2.0-32144454173
58. Ketelhuth D. F., Hansson G. K., Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thrombosis & Haemostasis 2011 106 5 779 786
59. Jäger A., Kuchroo V. K., Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scandinavian Journal of Immunology 2010 72 3 173 184 2-s2.0-77955288962 10.1111/j.1365-3083.2010.02432.x
60. George J., Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis. Nature Clinical Practice Cardiovascular Medicine 2008 5 9 531 540 2-s2.0-50649124207 10.1038/ncpcardio1279
61. + regulatory T cells. Nature Immunology 2003 4 4 330 336 2-s2.0-0037385330 10.1038/ni904 (Pubitemid 36432314)
62. Hori S., Nomura T., Sakaguchi S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 5609 1057 1061 2-s2.0-0347785480 10.1126/science.1079490 (Pubitemid 36222930)
63. Ait-Oufella H., Salomon B. L., Potteaux S., Robertson A. K. L., Gourdy P., Zoll J., Merval R., Esposito B., Cohen J. L., Fisson S., Flavell R. A., Hansson G. K., Klatzmann D., Tedgui A., Mallat Z., Natural regulatory T cells control the development of atherosclerosis in mice. Nature Medicine 2006 12 2 178 180 2-s2.0-32244445416 10.1038/nm1343 (Pubitemid 43214743)
64. + regulatory T cells in experimental atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 893 900 2-s2.0-34247190299 10.1161/01.ATV.0000259365.31469.89 (Pubitemid 46606722)
65. + regulatory T cells in patients with acute coronary syndromes. European Heart Journal 2006 27 21 2530 2537 2-s2.0-33750314730 10.1093/eurheartj/ehl222 (Pubitemid 44627295)
66. + Tregs and T helper 1 cells in acute coronary syndromes. Clinical Immunology 2007 124 1 90 97 2-s2.0-34250628384 10.1016/j.clim.2007.03.546 (Pubitemid 46936250)
67. Cheng X., Yu X., Ding Y. J., Fu Q. Q., Xie J. J., Tang T. T., Yao R., Chen Y., Liao Y. H., The Th17/Treg imbalance in patients with acute coronary syndrome. Clinical Immunology 2008 127 1 89 97 2-s2.0-40849130955 10.1016/j.clim.2008.01.009
68. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A., Cytokine network and T cell immunity in atherosclerosis. Seminars in Immunopathology 2009 31 1 23 33 2-s2.0-67749139468 10.1007/s00281-009-0143-x
69. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M. F., Soubrier F., Esposito B., Duez H., Fievet C., Staels B., Duverger N., Scherman D., Tedgui A., Protective role of interleukin-10 in atherosclerosis. Circulation Research 1999 85 8 e17 e24 2-s2.0-0033569130
70. Smith D. A., Irving S. D., Sheldon J., Cole D., Kaski J. C., Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001 104 7 746 749 2-s2.0-0035859839 (Pubitemid 32762668)
71. Mallat Z., Gojova A., Marchiol-Fournigault C., Esposito B., Kamaté C., Merval R., Fradelizi D., Tedgui A., Inhibition of transforming growth factor- β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circulation Research 2001 89 10 930 934 2-s2.0-0035834818 (Pubitemid 34627899)
72. Caligiuri G., Rudling M., Ollivier V., Jacob M. P., Michel J. B., Hansson G. K., Nicoletti A., Interleukin- 10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Molecular Medicine 2003 9 1-2 10 17 2-s2.0-0038544576 (Pubitemid 36667687)
73. Mallat Z., Gojova A., Brun V., Esposito B., Fournier N., Cottrez F., Tedgui A., Groux H., Induction of a regulatory T cell type I response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003 108 10 1232 1237 2-s2.0-0041915628 10.1161/01.CIR.0000089083. 61317.A1 (Pubitemid 37099993)
74. Voelkl S., Gary R., Mackensen A., Characterization of the immunoregulatory function of human TCR- α β + CD4- CD8- double-negative T cells. European Journal of Immunology 2011 41 3 739 748 2-s2.0-79954431750 10.1002/eji.201040982
75. + T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. American Journal of Pathology 2004 165 6 2013 2018 2-s2.0-9644308103 (Pubitemid 39578379)
76. Olofsson P. S., Söderström L. Å., Wågsäter D., Sheikine Y., Ocaya P., Lang F., Rabu C., Chen L., Rudling M., Aukrust P., Hedin U., Paulsson-Berne G., Sirsjö A., Hansson G. K., CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 2008 117 10 1292 1301 2-s2.0-40549112657 10.1161/CIRCULATIONAHA.107.699173 (Pubitemid 351365671)
77. Caligiuri G., Paulsson G., Nicoletti A., Maseri A., Hansson G. K., Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000 102 10 1114 1119 2-s2.0-0034609581
78. Stemme S., Faber B., Holm J., Wiklund O., Witztum J. L., Hansson G. K., T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America 1995 92 9 3893 3897 2-s2.0-0029053557
79. Benagiano M., Azzurri A., Ciervo A., T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America 2003 100 11 6658 6663 (Pubitemid 36666637)
80. Benagiano M., Munari F., Ciervo A., Chlamydophila pneumoniae phospholipase D, (CpPLD) drives Th17 inflammation in human atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 2012 109 4 1222 1227
81. Madjid M., Naghavi M., Litovsky S., Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003 108 22 2730 2736 (Pubitemid 37498972)
82. Dong M., Liu T., Li G., Association between acute infections and risk of acute coronary syndrome: a meta-analysis. International Journal of Cardiology 2011 147 3 479 482 2-s2.0-79952485785 10.1016/j.ijcard.2011.01.035
83. Tiirola T., Sinisalo J., Nieminen M. S., Silvennoinen-Kassinen S., Paldanius M., Saikku P., Jauhiainen M., Leinonen M., Chlamydial lipopolysaccharide is present in serum during acute coronary syndrome and correlates with CRP levels. Atherosclerosis 2007 194 2 403 407 2-s2.0-34948842035 10.1016/j.atherosclerosis.2006.08.013 (Pubitemid 47520617)
84. Shah P. K., Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiology in Review 2000 8 1 31 39 2-s2.0-0033954683 (Pubitemid 30053979)
85. Rosenfeld M. E., Campbell L. A., Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thrombosis & Haemostasis 2011 106 5 858 867
86. Matusik P., Guzik B., Weber C., Guzik T. J., Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thrombosis & Haemostasis 2012 108 3 443 456
87. Nilsson J., Hansson G. K., Autoimmunity in atherosclerosis: a protective response losing control? Journal of Internal Medicine 2008 263 5 464 478 2-s2.0-42149190800 10.1111/j.1365-2796.2008.01945.x (Pubitemid 351533555)
88. Binder C. J., Chang M. K., Shaw P. X., Miller Y. I., Hartvigsen K., Dewan A., Witztum J. L., Innate and acquired immunity in atherogenesis. Nature Medicine 2002 8 11 1218 1226 2-s2.0-0036852824 10.1038/nm1102-1218 (Pubitemid 35373552)
89. Frostegard J., Wu R., Giscombe R., Holm G., Lefvert A. K., Nilsson J., Induction of T-cell activation by oxidized low density lipoprotein. Arteriosclerosis and Thrombosis 1992 12 4 461 467 2-s2.0-0026566678
90. Wick G., Knoflach M., Xu Q., Autoimmune and inflammatory mechanisms in atherosclerosis. Annual Review of Immunology 2004 22 361 403 2-s2.0-2542498855 10.1146/annurev.immunol.22.012703.104644 (Pubitemid 38680427)
91. Mehta T. A., Greenman J., Ettelaie C., Venkatasubramaniam A., Chetter I. C., McCollum P. T., Heat shock proteins in vascular disease-a review. European Journal of Vascular and Endovascular Surgery 2005 29 4 395 402 2-s2.0-14744285580 10.1016/j.ejvs.2005.01.005 (Pubitemid 40331376)
92. Pockley A. G., Heat shock proteins, inflammation, and cardiovascular disease. Circulation 2002 105 8 1012 1017 2-s2.0-0037176975 10.1161/hc0802. 103729 (Pubitemid 34184583)
93. Benagiano M., D'Elios M. M., Amedei A., Azzurri A., Van Der Zee R., Ciervo A., Rombolà G., Romagnani S., Cassone A., Del Prete G., Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. Journal of Immunology 2005 174 10 6509 6517 2-s2.0-20844460614 (Pubitemid 40663846)
94. Park H. K., Park E. C., Bae S. W., Park M. Y., Kim S. W., Yoo H. S., Tudev M., Ko Y. H., Choi Y. H., Kim S., Kim D. I., Kim Y. W., Lee B. B., Yoon J. B., Park J. E., Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006 114 9 886 893 2-s2.0-33748372961 10.1161/CIRCULATIONAHA.105.541219 (Pubitemid 44337131)
95. Van Puijvelde G. H. M., Van Es T., Van Wanrooij E. J. A., Habets K. L. L., De Vos P., Van Der Zee R., Van Eden W., Van Berkel T. J. C., Kuiper J., Induction of oral tolerance to HSP60 or an HSP60-peptide activates t cell regulation and reduces atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 12 2677 2683 2-s2.0-36348993684 10.1161/ATVBAHA.107. 151274 (Pubitemid 350158922)
96. Delgado Roche L., Hernández D. A., New alternatives for atherosclerosis treatment based on immunomodulation. ISRN Vascular Medicine 2012 2012 785094
97. Businaro R., Profumo E., Tagliani A., Buttari B., Leone S., D'Amati G., Ippoliti F., Leopizzi M., D'Arcangelo D., Capoano R., Fumagalli L., Salvati B., Riganò R., Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 2009 207 1 74 83 2-s2.0-70350566676 10.1016/j.atherosclerosis.2009.04.026
98. Profumo E., Buttari B., Riganò R., Oxidative stress in cardiovascular inflammation: its involvement in autoimmune responses. International Journal of Inflammation 2011 2011 295705
99. Doring Y., Manthey H. D., Drechsler M., Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 2012 125 13 1673 1683
100. Van Vre E. A., Ait-Oufella H., Tedgui A., Apoptotic cell death and efferocytosis in atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology 2012 32 4 887 893
101. Shoenfeld Y., Gerli R., Doria A., Matsuura E., Cerinic M. M., Ronda N., Jara L. J., Abu-Shakra M., Meroni P. L., Sherer Y., Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005 112 21 3337 3347 2-s2.0-32644443487 10.1161/CIRCULATIONAHA.104.507996 (Pubitemid 43739380)
102. Profumo E., Buttari B., Alessandri C., Conti F., Capoano R., Valesini G., Salvati B., Riganò R., Beta2-glycoprotein I is a target of t cell reactivity in patients with advanced carotid atherosclerotic plaques. International Journal of Immunopathology and Pharmacology 2010 23 1 73 80 2-s2.0-77951718243
103. Buttari B., Profumo E., Mattei V., Siracusano A., Ortona E., Margutti P., Salvati B., Sorice M., Riganò R., Oxidized β 2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood 2005 106 12 3880 3887 2-s2.0-28444445251 10.1182/blood-2005-03-1201 (Pubitemid 41739027)
104. Buttari B., Profumo E., Capozzi A., Facchiano F., Saso L., Sorice M., Riganò R., Advanced glycation end products of human β 2 glycoprotein I modulate the maturation and function of DCs. Blood 2011 117 23 6152 6161 2-s2.0-79959483052 10.1182/blood-2010-12-325514
105. Profumo E., Buttari B., Riganò R., Oxidized haemoglobin as antigenic target of cell-mediated immune reactions in patients with carotid atherosclerosis. Autoimmunity Reviews 2009 8 7 558 562 2-s2.0-67349140906 10.1016/j.autrev.2009.01.016
106. Levy A. P., Moreno P. R., Intraplaque hemorrhage. Current Molecular Medicine 2006 6 5 479 488 2-s2.0-33747293850 10.2174/156652406778018626
107. Libby P., Ridker P. M., Hansson G. K., Progress and challenges in translating the biology of atherosclerosis. Nature 2011 473 7347 317 325 2-s2.0-79956319051 10.1038/nature10146
108. Hansson G. K., Nilsson J., Vaccination against atherosclerosis? Induction of atheroprotective immunity. Seminars in Immunopathology 2009 31 1 95 101 2-s2.0-67749133396 10.1007/s00281-009-0151-x
109. Van Puijvelde G. H. M., Hauer A. D., De Vos P., Van Den Heuvel R., Van Herwijnen M. J. C., Van Der Zee R., Van Eden W., Van Berkel T. J. C., Kuiper J., Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 2006 114 18 1968 1976 2-s2.0-33750502631 10.1161/CIRCULATIONAHA.106.615609 (Pubitemid 44665392)
110. Maron R., Sukhova G., Faria A. M., Hoffmann E., Mach F., Libby P., Weiner H. L., Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002 106 13 1708 1715 2-s2.0-0037167684 10.1161/01.CIR.0000029750.99462.30
111. George J., Yacov N., Breitbart E., Bangio L., Shaish A., Gilburd B., Shoenfeld Y., Harats D., Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with β 2-glycoprotein I. Cardiovascular Research 2004 62 3 603 609 2-s2.0-2442417320 10.1016/j.cardiores.2004.01.028 (Pubitemid 38648975)